Investor News

Isodiol Logo

Isodiol International Inc. Reports Fiscal Q2 2019 Financial Results

November 30, 2018 – Vancouver, BC – Isodiol International Inc. (CSE: ISOL) (OTCQB: ISOLF) (FSE: LB6B.F) (the “Company” or “Isodiol”) announces its financial and operational results for the second quarter of fiscal 2019, ended September 30, 2018. Second Quarter Highlights include: Total Revenue of $8,030,825 with gross profit of $4,317,612.…

Read More
Isodiol Logo

Isodiol International Inc. Appoints Board Member

November 21, 2018 – Vancouver, BC – Isodiol International Inc. (CSE: ISOL) (OTCQB: ISOLF) (FSE: LB6B.F) (the “Company” or “Isodiol”) is pleased to announce the appointment of Mr. Leonardo Matesanz to its board of directors. Mr. Matesanz boasts extensive experience in executive planning, strategy, and management and has served as…

Read More

Isodiol International Inc. Announces Update to Previously Announced Convertible Debenture Offering

November 19, 2018 – Vancouver, BC – Isodiol International Inc. (CSE: ISOL) (OTCQB: ISOLF) (FSE: LB6B.F) (the “Company” or “Isodiol”) ) is pleased to announce that it has entered into a financial advisory agreement (the “Agreement”) with Haywood Securities Inc. and Clarus Securities Inc. (the “Co-Advisors”) to act as financial…

Read More

Isodiol International Inc. Announces a Research & Development Partnership with Record Street Brewing Co. for Hemp-Based Beers and Functional Beverages

November 14, 2018 – Vancouver, BC – Isodiol International Inc. (CSE: ISOL) (OTCQB: ISOLF) (FSE: LB6B.F) (the “Company” or “Isodiol”) announced today that it has entered into an agreement on November 12, 2018 with Record Street Brewing Co. (“Record Street”), a music culture and lifestyle branded craft-beer company based in…

Read More

Isodiol International Inc. & Brew Hub, LLC Announce Agreement for the Development of Hemp Beer and Related Functional Beverages

November 13, 2018 – Vancouver, BC – Isodiol International Inc. (CSE: ISOL) (OTCQB: ISOLF) (FSE: LB6B.F) (the “Company” or “Isodiol”) announced today that its wholly owned subsidiary, IsoBev International Inc. (“IsoBev”), has executed an agreement with Brew Hub, LLC (“Brew Hub”) for the exclusive development and manufacturing of hemp, cannabis, hemp-derived,…

Read More

Isodiol International Inc. Provides Update on Mexico Operations and US Farm Bill

November 12, 2018 – Vancouver, BC – Isodiol International Inc. (CSE: ISOL) (OTCQB: ISOLF) (FSE: LB6B.F) (the “Company” or “Isodiol”), would like to update shareholders on its operations in Mexico. On October 30, 2018, regulations for CBD products were published by COFEPRIS.  The regulations include that products made from hemp are…

Read More

Isodiol International Inc. Announces Minimum $5,000,000 and Maximum $10,000,000 Convertible Debenture Offering

November 7, 2018 – Vancouver, BC – Isodiol International Inc. (CSE: ISOL) (OTCQB: ISOLF) (FSE: LB6B.F) (the “Company” or “Isodiol”) is pleased to announce that it has entered into an engagement agreement with Haywood Securities Inc. (“Haywood”), to act as sole book runner and co-lead agent with Clarus Securities Inc. (together…

Read More

Isodiol International Inc. Set to Debut New CBD Beverage Ingredient, Heneplex p200 ™, at Supply Side West and Provides Shareholder Update

November 5, 2018 – Vancouver, BC – Isodiol International Inc. (CSE: ISOL) (OTCQB: ISOLF) (FSE: LB6B.F) (the “Company” or “Isodiol”) is set to debut its newest CBD raw ingredient, Heneplex p200 ™, at Supply Side West in Las Vegas November 8th and 9th, 2018, booth 1557, to meet the new demand…

Read More

Isodiol International Inc. Announces Appointment of Franco Columbu to Iso-Sport Management Team

October 29, 2018 – Vancouver, BC – Isodiol International Inc. (CSE: ISOL) (OTCQB: ISOLF) (FSE: LB6B.F) (the “Company” or “Isodiol”), is pleased to announce that actor, author, former champion bodybuilder and World’s Strongest Man competitor, Franco Columbu, has joined the management team at Iso-Sport. Mr. Columbu will focus on the business…

Read More
ISO SPORT - CBD performance products

ISO-SPORT™ Products Now Available Through Two UK-based Mixed Martial Arts Companies

October 16, 2018 – Vancouver, BC – Isodiol International Inc. (CSE: ISOL) (OTCQB: ISOLF) (FSE: LB6B.F) (the “Company” or “Isodiol”), is pleased to announce that its subsidiary, ISO-SPORT ™, has reached deals with two United Kingdom-based mixed martial arts retailers to sell the CBD Performance Products. Acclaimed as being two of…

Read More

Isodiol International Inc. Applauds the U.K. Government’s Decision to Legalize Medical Cannabis

October 15, 2018 – Vancouver, BC – Isodiol International Inc. (CSE: ISOL) (OTCQB: ISOLF) (FSE: LB6A.F) (the “Company” or “Isodiol”) applauds the Government of the United Kingdom’s on its decision to legalize medical cannabis and allow expert doctors to have an option to prescribe cannabis-based medicines in England, Whales and Scotland. …

Read More

Isodiol International Inc. Announces Plans to Enter Pet Industry with All-Natural CBD Supplement Line

October 15, 2018 – Vancouver, BC – Isodiol International Inc. (CSE: ISOL) (OTCQB: ISOLF) (FSE: LB6A.F) (the “Company” or “Isodiol”) announced today it will be launching Pawceuticals, a CBD-based product line that naturally aids in restoring a pet’s health and improving overall wellness. The Pawceuticals functional CBD pet products are designed…

Read More

BSPG Laboratories Ltd., a Subsidiary of Isodiol International Inc., Launches API Sales and Marketing Program at CPhI 2018

October 5, 2018 – Vancouver, BC – Isodiol International Inc. (CSE: ISOL) (OTCQB: ISOLF) (FSE: LB6A.F) (the “Company” or “Isodiol”), is pleased to offer a reliable source of GMP-compliant cannabidiol (CBD), extracted from industrial hemp to pharmaceutical companies and research groups for human and animal use at CPhI 2018 in Madrid,…

Read More

Isodiol International Inc. Applauds U.S. Drug Enforcement Agency ( DEA ) Rescheduling of Select Pharmaceuticals Made with Cannabidiol ( CBD )

September 28, 2018 – Vancouver, BC – Isodiol International Inc. (CSE: ISOL) (OTCQB: ISOLF) (FSE: LB6A.F) (the “Company” or “Isodiol”) applauds the Drug Enforcement Administration’s (DEA) decision in the long-anticipated rescheduling of CBD following the Federal Drug Administration’s (FDA) approval of GW Pharmaceutical’s FPP, Epidiolex, for the treatment of seizures associated with…

Read More
Isodiol Logo

Isodiol International Inc. Appoints Patrick Ogle as Chief Operating Officer and as a member of its Board of Directors; Appoints Dr. David Putrino, Ph.D., to Medical Advisory Board

September 14, 2018 – Vancouver, BC – Isodiol International Inc. (CSE: ISOL) (OTC: ISOLF) (FSE: LB6A.F) (the “Company”)  announces that its general counsel for M&A, Corporate and Securities, Patrick Ogle has been appointed as the Company’s Chief Operating Officer (“COO”) and as a member of its Board of Directors. Mr. Ogle…

Read More